WOW! The toxicity of these agents and many othe
Post# of 144804
The toxicity of these agents and many others is under evaluation in clinical trials to determine their effectiveness against COVID-19. Data has already begun to be shared with the FDA from some clinical trials, such as leronlimab, which had data recently published in a pre-print manuscript online. The FDA intends to engage with pharmaceutical sponsors and other government agencies to facilitate patient access to these potential treatments as soon as favorable results are seen.>>
https://www.targetedonc.com/view/fda-advances...-treatment
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
CytoDyn Inc (CYDY) Stock Research Links
Le-Ron-Li-Mab, and they have not.